Related Experiment Videos
Coronary drug-eluting stent development: issues in trial design
Neal I Muni1, Robert M Califf, Jonette R Foy
1Center for Devices and Radiological Health, U.S. Food and Drug Administration, Rockville, Md 20850, USA. neal.muni@fda.hhs.gov
American Heart Journal
|May 3, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Early technology review during prototype development and at proof of concept: the case for developing a sequential versus a single-stage approach to early evidence development for health technologies.
International journal of technology assessment in health care·2026
Early technology review: towards an expedited pathway.
International journal of technology assessment in health care·2024
An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the US.
International journal of pharmaceutics·2022
Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art Review.
Journal of the American College of Cardiology·2020
Transcatheter valve therapy registry is a model for medical device innovation and surveillance.
Health affairs (Project Hope)·2015
The reporting of blinding in physical medicine and rehabilitation randomized controlled trials: a systematic review.
Journal of rehabilitation medicine·2012
Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.
American heart journal·2026
Pregnancy Outcomes in Women with a History of Myocarditis.
American heart journal·2026
Neuroprotective effects of gallic acid against docetaxel-induced peripheral neuropathy: behavioral, molecular, and histopathological evidence.
Molecular and cellular biochemistry·2026
Metabolic cell death: ferroptosis, cuproptosis, and disulfidptosis as a unified framework for targeting metabolic vulnerabilities in disease.
Apoptosis : an international journal on programmed cell death·2026
The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
From Dynamics to Diagnosis and Therapy: A Multiscale Computational Framework for MALT1-Targeted Cancer Theranostics.
Journal of chemical information and modeling·2026
Collaborations with Miral Dizdaroglu: expanding on connections between oxidative DNA damage and aging and disease.
International journal of radiation biology·2026